Vetter, a pharmaceutical service provider for the production of injectable drugs, has announced plans to build a new ...

Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...

Opentrons Labworks has made public its promotion of James Atwood to the position of Chief Executive Officer. In announcing ...

IQVIA and its Data-as-a-Service (DaaS+) technology have been chosen by Boehringer Ingelheim in a new, strategic long-term ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.

Potency assays are central to proving a therapy activity and safety, yet for advanced therapies like cell and gene therapies ...

Cell and gene therapies (CGTs) are revolutionizing treatment, but increasing regulatory scrutiny has led to a rise in costly ...

WuXi Biologics and Sinorda Biomedicine have jointly announced a strategic collaboration for the development and manufacturing of SND006.

Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment by combining the selectivity of monoclonal antibodies with the potency of cytotoxic drugs. However, the unique ...

Halozyme has acquired Surf Bio for an upfront payment of $300 million, subject to customary purchase price adjustments, and up to $100 million milestone payments based on product development and ...

Satellos Bioscience Inc., a clinical-stage biotechnology company, has appointed Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs.

How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, ...